BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25784010)

  • 1. Toxin-secreting implantable therapeutic stem cells.
    Gamble AJ; Boockvar JA
    Neurosurgery; 2015 Apr; 76(4):N16-8. PubMed ID: 25784010
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
    Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
    Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model.
    Yu D; Li G; Lesniak MS; Balyasnikova IV
    J Vis Exp; 2017 Jun; (124):. PubMed ID: 28605391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioblastoma multiforme: can neural stem cells deliver the therapeutic payload and fulfill the clinical promise?
    Ahmed AU; Lesniak MS
    Expert Rev Neurother; 2011 Jun; 11(6):775-7. PubMed ID: 21651324
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells.
    Bagci-Onder T; Du W; Figueiredo JL; Martinez-Quintanilla J; Shah K
    Brain; 2015 Jun; 138(Pt 6):1710-21. PubMed ID: 25910782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma.
    Reitz M; Demestre M; Sedlacik J; Meissner H; Fiehler J; Kim SU; Westphal M; Schmidt NO
    Stem Cells Transl Med; 2012 Dec; 1(12):866-73. PubMed ID: 23283548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy evaluations of an adeno-associated virus variant for preparing IL10-secreting human neural stem cell-based therapeutics.
    Cho M; Jung K; Kim SH; Kim IS; Kim M; Shin M; Lee H; Park KI; Jang JH
    Gene Ther; 2019 May; 26(5):135-150. PubMed ID: 30692604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural stem cell-mediated enzyme/prodrug therapy for glioma.
    Parry PV; Engh JA
    Neurosurgery; 2013 Aug; 73(2):N16-8. PubMed ID: 23867271
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.
    Li G; Bonamici N; Dey M; Lesniak MS; Balyasnikova IV
    Expert Opin Drug Deliv; 2018 Feb; 15(2):163-172. PubMed ID: 28895435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering toxin-resistant therapeutic stem cells to treat brain tumors.
    Stuckey DW; Hingtgen SD; Karakas N; Rich BE; Shah K
    Stem Cells; 2015 Feb; 33(2):589-600. PubMed ID: 25346520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma multiforme: Pathogenesis and treatment.
    Alifieris C; Trafalis DT
    Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma stem cell research for the development of immunotherapy.
    Xu Q; Yuan X; Yu JS
    Adv Exp Med Biol; 2012; 746():216-25. PubMed ID: 22639171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell therapies for glioblastoma.
    Terzis AJ; Niclou SP; Rajcevic U; Danzeisen C; Bjerkvig R
    Expert Opin Biol Ther; 2006 Aug; 6(8):739-49. PubMed ID: 16856796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme.
    Miska J; Lesniak MS
    EBioMedicine; 2015 Aug; 2(8):774-5. PubMed ID: 26425671
    [No Abstract]   [Full Text] [Related]  

  • 15. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.
    Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C
    Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells for treating glioblastoma: how close to reality?
    James CD; Cavenee WK
    Neuro Oncol; 2009 Apr; 11(2):101. PubMed ID: 19237733
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of neural stem cells in cancer gene therapy: predicting the path to the clinic.
    Ahmed AU; Alexiades NG; Lesniak MS
    Curr Opin Mol Ther; 2010 Oct; 12(5):546-52. PubMed ID: 20886386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural Stem Cell-Based Therapies and Glioblastoma Management: Current Evidence and Clinical Challenges.
    Benmelouka AY; Munir M; Sayed A; Attia MS; Ali MM; Negida A; Alghamdi BS; Kamal MA; Barreto GE; Ashraf GM; Meshref M; Bahbah EI
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The principles of molecular therapies for glioblastoma.
    Karpati G; Nalbantoglu J
    Int Rev Neurobiol; 2003; 55():151-63. PubMed ID: 12968535
    [No Abstract]   [Full Text] [Related]  

  • 20. Stem cell-based therapies for tumors in the brain: are we there yet?
    Shah K
    Neuro Oncol; 2016 Aug; 18(8):1066-78. PubMed ID: 27282399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.